Dudediligence.

Cytokinetics, Incorporated

CYTKNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Other eventsAug 28 →InsidersNo open-market buys. 9 insiders sold $32.4M, 53 of 63 sales on a 10b5-1 plan.→HoldersBlackRock 16.3%Wellington Management Group LLP 5.6%Vanguard Portfolio 5.5%→PeersClosest companies: EXEL, INCY, AKBA→

From the filings

Figures

Revenue
$67.7Mlast 12 months
Net income
−$894.0Mlast 12 months
Operating cash flow
−$523.8Mlast 12 months
Cash and equivalents
$255.3Mat the last balance sheet
Total debt
$275.6Mat the last balance sheet
Shares outstanding
122.9M shareson issue
Every year and quarter →